Insider Transactions in Q1 2022 at Paratek Pharmaceuticals, Inc. (PRTK)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 15
2022
|
Michael Bigham Exec. Chairman of the Board |
BUY
Grant, award, or other acquisition
|
Direct |
202,500
+15.63%
|
-
|
|
Mar 15
2022
|
Randall B. Brenner Chief Development & Regulatory |
BUY
Grant, award, or other acquisition
|
Direct |
67,500
+17.37%
|
-
|
|
Mar 15
2022
|
William M. Haskel CLO, General Counsel & Sec. |
BUY
Grant, award, or other acquisition
|
Direct |
67,500
+14.21%
|
-
|
|
Mar 15
2022
|
Evan Loh CEO |
BUY
Grant, award, or other acquisition
|
Direct |
236,250
+17.05%
|
-
|
|
Mar 15
2022
|
Adam Woodrow President & Chief Commercial |
BUY
Grant, award, or other acquisition
|
Direct |
101,250
+15.23%
|
-
|
|
Feb 16
2022
|
Minnie Baylor Henry Director |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+33.78%
|
-
|
|
Feb 16
2022
|
Thomas John Dietz Director |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+28.57%
|
-
|
|
Feb 16
2022
|
Timothy R Franson Director |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+25.32%
|
-
|
|
Feb 16
2022
|
Rolf K Hoffmann Director |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+23.81%
|
-
|
|
Feb 16
2022
|
Kristine Peterson Director |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+25.32%
|
-
|
|
Feb 16
2022
|
Robert S Radie Director |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+27.68%
|
-
|
|
Feb 16
2022
|
Jeffrey Stein Director |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+26.45%
|
-
|